XALUPRINE susp 20 mg/ml fl 100 ml
7680653710018
CH-65371
L01BB02
07.16.1.
Active substances:
1 / 3
google
Details
- Product number
- 6537101
- CPT
- -
- Packaging group
- 100
- Unit
- ml
- Composition
- mercaptopurinum monohydricum 20 mg, xanthani gummi, aspartamum 3 mg, rubi idaei succus concentratus cum saccharum max. 32 mg et E 220 max. 0.24 mg, E 219 1.15 mg, E 215 0.57 mg, E 202, natrii hydroxidum, aqua purificata ad suspensionem pro 1 ml corresp. natrium max. 0.68 mg.
Articles (1)
Xaluprine 20 mg/ml, Suspension zum Einnehmen
suspension
100
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
mercaptopurinum monohydricum
|
20.0 MG | Substance | Wirkstoff (Principe actif) |
|
xanthani gummi
|
- | Substance | HNIDK |
|
aspartamum
|
3.0 MG | Substance | HBESI |
|
rubi idaei succus concentratus
|
- | Substance | HNIDK |
|
saccharum
|
- | Substance | HBESI |
|
E 220
|
- | Substance | HBESI |
|
E 219
|
1.15 MG | Substance | HBESI |
|
E 215
|
0.57 MG | Substance | HBESI |
|
E 202
|
- | Substance | Konservierungsstoff (Conservateur) |
|
natrii hydroxidum
|
- | Substance | HNIDK |
|
aqua purificata
|
- | Substance | HNIDK |
|
natrium
|
- | Substance | HBESI |
Reimbursement information
Public price
CHF 292.00
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/06/2025
Authorization holder
Lipomed AG
4144 Arlesheim
Authorization information
- Swissmedic authorization number
- 65371
- Drug name
- Xaluprine 20 mg/ml, Suspension zum Einnehmen
- Galenic form
- SUOR
- ATC Code
- L01BB02
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 18/12/2014
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- XALUPRINE susp 20 mg/ml fl 100 ml
- Description (DE)
- XALUPRINE Susp 20 mg/ml Fl 100 ml
- Market launch
- 18/12/2014
- Narcotic (BTM)
- No